Resveratrol and red wine consumption

Human and Experimental Toxicology

Volumn 18, Issue 10, 1999, Pages 625-626

  Slater, I ^a   Odum, J ^a   Ashby, J ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Bone density; Cholesterol; Estrogen; Phytoestrogen; Resveratrol; Uterus

Indexed keywords

ESTROGEN RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RESVERATROL;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE MINERAL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; UTERUS WEIGHT; WINE;

ANIMALIA;

EID: 0032708982     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/096032799678839464     Document Type: Article

References (5)

1. Gehm BD, McAndrews JM, Chein P-Y, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Nat Acad Sci 1997; 94: 14138-14143.
2. Ashby J et al. Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects. J Applied Toxicol 1999; 19: 39-45.
3. Turner RT et al. Is resveratrol an estrogen agonist in growing rats? Endocrinology 1999; 140: 50-54.
4. Ashby J, Odum J, Foster JR. Activity of raloxifene in immature and ovariectomized rat uterotrophic assays. Regul Toxicol Pharmacol 1997; 25: 226-231.
5. Dukes M, Chester R, Yarwood L, Wakeling AE. Effects of a non-steroidal pure antioestrogen, ZM 189,154, on oestrogen target organs of the rat including bones. J Endocrinol 1994; 141: 335-341.